<DOC>
	<DOCNO>NCT00572819</DOCNO>
	<brief_summary>The aim study investigate whether 1000 microgram self-administered vaginal misoprostol 12 hour operative hysteroscopy result effective preoperative cervical ripen two week pretreatment 25 microgram daily vaginal estradiol , compare placebo ( lactosum monohydricum ) postmenopausal woman .</brief_summary>
	<brief_title>Hysteroscopy After Pretreatment With Misoprostol Estradiol Trial</brief_title>
	<detailed_description />
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<mesh_term>Misoprostol</mesh_term>
	<criteria>All postmenopausal ( &gt; one year since last menstruation ) woman refer outpatient hysteroscopy medical indication hysteroscopy , give informed consent , eligible study recruitment Women wish participate Women medically unfit hysteroscopy Women medically unfit participation clinical trial Women medical indication hysteroscopy Women previously , currently breast gynaecological cancer Women medical contraindication locally apply oestradiol Women currently use hormone therapy Women unable communicate Norwegian , Women know allergy misoprostol</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>Hysteroscopy</keyword>
	<keyword>Misoprostol</keyword>
	<keyword>Postmenopausal woman</keyword>
	<keyword>Cervical ripening</keyword>
	<keyword>Dilatation</keyword>
	<keyword>Sequential trial</keyword>
	<keyword>Estradiol</keyword>
</DOC>